INS and metabolic dysfunction-associated steatotic liver disease: This study is currently underway and is aimed to demonstrate that 12-week MedDiet can result in significant benefits in liver fat and insulin sensitivity and these changes are sustained at 12 months in patients with NAFLD who are insulin resistant.